Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T
Tóm tắt
Từ khóa
Tài liệu tham khảo
Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269–275
Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE, Haraldseth O (1999) Characterization of neoplastic and normal human breast tissues with in vivo 1 spectroscopy. J Magn Reson Imaging 10:159–164
Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 220:40–60
Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45–54
Katz-Brull R, Lavin PT, Lenkinski R (2002) Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 94:1197–1203
Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016–1022
Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M (2003) In vivo quantification of choline compounds in the breast with 1 Spectroscopy. Magn Reson Med 50:1134–1143
Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75
Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA (2001) External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 46:189–192
Vanhamme L, van den Boogaart A, Huffel SV (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43
Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348
Ordidge RJ, Bendall MR, Gordon RE, Connelly A (1985). Volume selection for in vivo spectroscopy. In: Govil G, Khetrapal CL, Sarans A (eds). Magnetic resonance in biology and medicine. Tata-McGraw-Hill, New Delhi, pp 387–397
Hasse A, Frahm J, Hanicke W, Mattaei (1985) 1 chemical shift selective (CHESS) imaging. Phys Med Biol 30:431
Doddrell DM, Galloway G, Brooks W, Filed J, Bulsing J, Irving M, Baddeley H (1986) Water signal elimination in vivo, using suppression by mistimed echo and repetitive gradient episodes. J Magn Reson 70:176–180
Naressim A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, Graveron-Demilly D (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141–152
Knijn A, de Beer R, van Ormondt D (1992) Frequency-selective quantification in the time domain. J Magn Reson 97:444–450
van den Bos A (1982) Parameter estimation. In: Sydenham PH (eds). Handbook of measurement science, vol 1. Wiley, Chichester 1, pp 33
Longo R, Bampo A, Vidimari R, Magnaldi S, Giorgini A (1995) Absolute quantitation of brain H-1 nuclear magnetic resonance spectra-comparison of different approaches. Invest Radiol 30:199–203
Negengank W (1992) Studies of human tumors by MRS: a review. NMR Biomed 5:303–324
Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL (1996) Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323–325
Marshall I, Bruce SD, Higinbotham J, MacLullich A, Waardlaw JM, Ferguson KJ, Seckl J (2000) Choice of spectroscopic lineshape model affects metabolite peak areas and area ratios. Magn Reson Med 44:651–657
Stanwell P, Gluch L, Clark D, Tomanek B, Baker L, Giuffre B, Lean C, Malycha P, Mountford C (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1 at 1.5 T. Eur Radiol 15:1037–1043
Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, Doran ST, Barraclough BH, Bilous M, Mountford CE (1997) Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 204:661–666
Cheng LL, Chang W, Smith BL, Gonzalez RG (1998) Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy. J Magn Reson 135:194–202
Gribbestad IS, Sitter B, Lundgren S, Krane J, Axelson D (1999) Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. Anticancer Res 19:1737–1746
Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS (2002) High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed 15(5):327–337
Gribbestad IS, Singstad TE, Nilsen G, Fjosne HE, Engan T, Haugen OA, Rinck PA (1993) In vitro proton NMR spectroscopy of extracts from human breast-tumors and noninvolved breast tissue. Anticancer Res 13:1973–1980
Gribbestad IS, Petersen SB, Fjosne HE, Kvinnsland S, Krane J (1994) H-1 NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and noninvolved breast tissue. NMR Biomed 7:181–194
Ting YT, Sherr D, Degani H (1996) Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 16:1381–1388
Katz-Brull R, Margalit R, Degani H (2001) differential routing of choline in implanted breast cancer and normal organs. Magn Reson Med 46:31–38
Aboagye EO, Bhujwalla ZM (1999) Malignant transformation alters membrane choline phospholipids metabolism of human mammary epithelial cells. Cancer Res 59:80–84
Podo F (1999) Tumour phospholipids metabolism. NMR Biomed 12:976–983